3.1.1.2: arylesterase
This is an abbreviated version!
For detailed information about arylesterase, go to the full flat file.
Word Map on EC 3.1.1.2
-
3.1.1.2
-
lipoprotein
-
cholesterol
-
high-density
-
atherosclerosis
-
cardiovascular
-
low-density
-
coronary
-
apolipoproteins
-
artery
-
triglyceride
-
organophosphate
-
malondialdehyde
-
hdl-associated
-
lactonase
-
anti-oxidant
-
atherogenic
-
mellitus
-
c-reactive
-
organophosphorus
-
pesticide
-
acetylcholinesterase
-
phenylacetate
-
lipoprotein-associated
-
hdl-cholesterol
-
homocysteine
-
atherogenesis
-
esterases
-
cholinesterase
-
apoa-i
-
antiatherogenic
-
qq
-
ox-ldl
-
chlorpyrifos
-
atheroprotective
-
oxons
-
butyrylcholinesterase
-
carboxylesterase
-
lipoprotein-cholesterol
-
paf-ah
-
lp-pla2
-
phosphotriesterase
-
parathion
-
soman
-
analysis
-
clopidogrel
-
acetylhydrolase
-
drug development
-
allozyme
-
oxidant-antioxidant
-
sarin
-
lecithin:cholesterol
-
medicine
-
thiolactone
- 3.1.1.2
- lipoprotein
- cholesterol
-
high-density
- atherosclerosis
- cardiovascular
-
low-density
- coronary
-
apolipoproteins
- artery
- triglyceride
-
organophosphate
- malondialdehyde
-
hdl-associated
- lactonase
-
anti-oxidant
-
atherogenic
- mellitus
-
c-reactive
-
organophosphorus
-
pesticide
- acetylcholinesterase
- phenylacetate
-
lipoprotein-associated
-
hdl-cholesterol
- homocysteine
- atherogenesis
- esterases
- cholinesterase
- apoa-i
-
antiatherogenic
-
ox-ldl
- chlorpyrifos
-
atheroprotective
-
oxons
- butyrylcholinesterase
- carboxylesterase
-
lipoprotein-cholesterol
- paf-ah
- lp-pla2
- phosphotriesterase
- parathion
- soman
- analysis
- clopidogrel
-
acetylhydrolase
- drug development
-
allozyme
-
oxidant-antioxidant
- sarin
-
lecithin:cholesterol
- medicine
-
thiolactone
Reaction
Synonyms
(R)-specific SGNH arylesterase, A-esterase, alpha-esterase, ARE, AREase, aromatic esterase, Aryl-ester hydrolase, aryldialkylphosphatase, arylesterase, DvvII, EST-1, EST-2, EST-3, ESt-A, Est0881, EstB, EstR5, G3C9 rePON1, gox0881, HDL-PON1, K-45, lp_1002, More, neuropathy target esterase-related esterase, NRE, NRECV, NTE-R1, NTE-related 1, NTE-related esterase, paraoxonase, paraoxonase 1, paraoxonase-1, paraoxonase/arylesterase, paraoxonase1, patatin-like phospholipase 7, phenyl acetate esterase, phenyl valerate esterase, PNPLA7, PON-aryl, PON1, PON1/Aryl, pyrethroid-resistance-associated esterase, Saci_2140, SacPox, serum paraoxonase/arylesterase 1, SGNH arylesterase, SGNH-arylesterase, SisLac, Sm23, Vmut2255, VmutPLL
ECTree
3.1.1.2 arylesteraseAdvanced search results
results (
results (Natural Substrates Products
Natural Substrates Products on EC 3.1.1.2 - arylesterase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
NATURAL SUBSTRATE 
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
additional information
?
-
-
the enzyme is one of the HDL-associated antioxidant proteins, overview
-
-
?
additional information
?
-
-
paraoxonase-1 is an enzyme with three activities which are inversely related to cardiovascular diseases, paraoxonase and arylesterase activities are involved in coronary artery disease, overview
-
-
?
additional information
?
-
-
polymorphisms allele frequency in relation to exposure of individuals to organophosphates, overview
-
-
?
additional information
?
-
polymorphisms allele frequency in relation to exposure of individuals to organophosphates, overview
-
-
?
additional information
?
-
PON1 hydrolyses esters, including organophosphates and lactones, and exhibits anti-atherogenic properties, the enzyme is associated to high-density-lipoprotein, bound together with the human phosphate binding protein
-
-
?
additional information
?
-
-
PON1 hydrolyses esters, including organophosphates and lactones, and exhibits anti-atherogenic properties, the enzyme is associated to high-density-lipoprotein, bound together with the human phosphate binding protein
-
-
?
additional information
?
-
-
the enzyme is important in the mechanism of organophosphorous toxicity
-
-
?
additional information
?
-
the enzyme is important in the mechanism of organophosphorous toxicity
-
-
?
additional information
?
-
PON1 hydrolyzes organophosphates, such as paraoxon, aromatic esters, for instance, phenyl acetate, and also lipid peroxidation products, and reduces the accumulation of them, PON1 prevents the acceleration of atherosclerosis, exhibits antioxidant ability, and assumes an antiatherogenic property. Negative correlation between the activity of PON1 and the level of lipid hydroperoxides in the rheumatoid arthritis patient group, overview
-
-
?
additional information
?
-
-
PON1 hydrolyzes organophosphates, such as paraoxon, aromatic esters, for instance, phenyl acetate, and also lipid peroxidation products, and reduces the accumulation of them, PON1 prevents the acceleration of atherosclerosis, exhibits antioxidant ability, and assumes an antiatherogenic property. Negative correlation between the activity of PON1 and the level of lipid hydroperoxides in the rheumatoid arthritis patient group, overview
-
-
?
additional information
?
-
PON1 is not able to prevent macrophage oxidative stress, however, is able to retard macrophage-induced low-density lipoprotein oxidation
-
-
?
additional information
?
-
-
PON1 is not able to prevent macrophage oxidative stress, however, is able to retard macrophage-induced low-density lipoprotein oxidation
-
-
?
additional information
?
-
PON1 plays a key role in the protection of low density lipoproteins and high density lipoproteins from oxidation by hydrolyzing activated phospholipids and lipid peroxide products
-
-
?
additional information
?
-
-
PON1 plays a key role in the protection of low density lipoproteins and high density lipoproteins from oxidation by hydrolyzing activated phospholipids and lipid peroxide products
-
-
?
additional information
?
-
the active site of the enzyme is characterized by two distinct binding regions, the hydrophobic binding site for arylesters/lactones and the paraoxon binding site for phosphotriesters
-
-
?
additional information
?
-
-
the active site of the enzyme is characterized by two distinct binding regions, the hydrophobic binding site for arylesters/lactones and the paraoxon binding site for phosphotriesters
-
-
?
additional information
?
-
the enzyme is located on high-density lipoprotein and prevents low-density-lipoprotein and high-density-lipoprotein oxidation both in vivo and in vitro through hydrolysis of lipid peroxides, the risk of ischemic stroke is related to the genotype of PON1 192RQ polymorphisms, overview
-
-
?
additional information
?
-
-
the enzyme is located on high-density lipoprotein and prevents low-density-lipoprotein and high-density-lipoprotein oxidation both in vivo and in vitro through hydrolysis of lipid peroxides, the risk of ischemic stroke is related to the genotype of PON1 192RQ polymorphisms, overview
-
-
?
